Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
BAT3 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
BAT3 Chaperone that plays a key role in various processes such as apoptosis, insertion of tail-anchored (TA) membrane proteins to the endoplasmic reticulum membrane and regulation of chromatin. Acts in part by regulating stability of proteins and their degradation by the proteasome. Participates in endoplasmic reticulum stress-induced apoptosis via its interaction with AIFM1/AIF by regulating AIFM1/AIF stability and preventing its degradation. Also required during spermatogenesis for synaptonemal complex assembly via its interaction with HSPA2, by inhibiting polyubiquitination and subsequent proteasomal degradation of HSPA2. Required for selective ubiquitin-mediated degradation of defective nascent chain polypeptides by the proteasome. In this context, may play a role in immuno-proteasomes to generate antigenic peptides via targeted degradation, thereby playing a role in antigen presentation in immune response. Key component of the BAG6/BAT3 complex, a cytosolic multiprotein complex involved in the post-translational delivery of tail-anchored (TA) membrane proteins to the endoplasmic reticulum membrane. TA membrane proteins, also named type II transmembrane proteins, contain a single C-terminal transmembrane region. BAG6/BAT3 acts by facilitating TA membrane proteins capture by ASNA1/TRC40: it is recruited to ribosomes synthesizing membrane proteins, interacts with the transmembrane region of newly released TA proteins and transfers them to ASNA1/TRC40 for targeting to the endoplasmic reticulum membrane. Component of the BAT3 complex, at least composed of BAG6/BAT3, UBL4A and GET3/TRC35. Interacts with AIFM1, CTCFL, HSPA2 and p300/EP300. Interacts with ricin A chain. Interacts with L.pneumophila proteins Lpg2160 and LegU1. Interacts with NCR3. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Ubiquitin conjugating system; Cell cycle regulation; Apoptosis; Chaperone
Cellular Component: cytosol; nucleus
Molecular Function: protein binding; ribosome binding; Hsp70 protein binding; polyubiquitin binding
Biological Process: ubiquitin-dependent protein catabolic process; negative regulation of proteolysis; synaptonemal complex assembly; internal peptidyl-lysine acetylation; protein stabilization; chromatin modification; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; regulation of cell proliferation; embryonic development; transport; spermatogenesis; brain development; cell differentiation; kidney development; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; lung development
Reference #:  P46379 (UniProtKB)
Alt. Names/Synonyms: BAG-6; BAG6; BAT3; D6S52E; G3; HLA-B associated transcript 3; HLA-B associated transcript-3; HLA-B-associated transcript 3; Large proline-rich protein BAT3; Protein G3; scythe
Gene Symbols: BAG6
Molecular weight: 119,409 Da
Basal Isoelectric point: 5.4  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

BAT3

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  DISEASE  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

► Hide Isoforms
 
0 1 - gap
0 1 S6-p __MEPNDsTSTAVEE
0 1 K22-u DSLEVLVkTLDsQTR
1 1 S26-p VLVkTLDsQTRTFIV
0 4 K40-u VGAQMNVkEFKEHIA
0 69 K56-u SVSIPSEkQRLIYQG
0 1 K56-a SVSIPSEkQRLIYQG
0 1 K70-u GRVLQDDkKLQEYNV
0 1 K71 RVLQDDkKLQEYNVG
0 9 K80-u QEYNVGGkVIHLVER
0 1 S106-p SSGTGSAsATHGGGs
0 7 S113-p sATHGGGsPPGtRGP
0 1 T117-p GGGsPPGtRGPGASV
0 1 S181-p RDIQTLLsRMETLPY
1 1 S218-p PEPVALSsQTSEPVE
0 25 T350-p LRCNLACtPPRHLHV
0 1 S697-p GLGLESLsPEFFTSV
0 2 Y818-p LITGLEEyVRESFSL
0 1 T915-p PSLVSWLtTMMGLRL
0 1 P949 RVGDPPQPLPEEPME
0 1 A963 EVQGAERAsPEPQRE
0 17 S964-p VQGAERAsPEPQREN
0 28 S973-p EPQRENAsPAPGttA
0 2 T978-p NAsPAPGttAEEAMS
0 1 T979-p AsPAPGttAEEAMSR
0 1 D1001-ca GGSRDEQdGASAETE
0 2 K1033-u IQSQRKVkPQPPLSD
0 1 K1049-u YLSGMPAkRRktMQG
0 3 K1052-u GMPAkRRktMQGEGP
0 5 T1053-p MPAkRRktMQGEGPQ
0 2 T1080-p AAGARPLtsPESLSR
0 23 S1081-p AGARPLtsPESLSRD
0 67 Y1116-p RLQEDPNysPQRFPN
0 17 S1117-p LQEDPNysPQRFPNA
  BAT3 iso4  
S18-p THAGVVRsPGRQRWR
S109 SAMEPNDSTSTAVEE
K125 DSLEVLVKTLDSQTR
S129 VLVKTLDSQTRTFIV
K143 VGAQMNVKEFKEHIA
K159 SVSIPSEKQRLIYQG
K159 SVSIPSEKQRLIYQG
K173 GRVLQDDKKLQEYNV
K174 RVLQDDKKLQEYNVG
K183 QEYNVGGKVIHLVER
S209 SSGTGSASATHGGGS
S216 SATHGGGSPPGTRGP
T220 GGGSPPGTRGPGASV
S284 RDIQTLLSRMECRGG
S315 PEPVALSSQTSEPVE
T447-p LRCNLACtPPRHLHV
S794 GLGLESLSPEFFTSV
Y915 LITGLEEYVRESFSL
T1012 PSLVSWLTTMMGLRL
P1046 RVGDPPQPLPEEPME
A1060 EVQGAERASPEPQRE
S1061 VQGAERASPEPQREN
S1070 EPQRENASPAPGTTA
T1075 NASPAPGTTAEEAMS
T1076 ASPAPGTTAEEAMSR
D1098 GGSRDEQDGASAETE
K1130 IQSQRKVKPQPPLSD
K1146 YLSGMPAKRRKTMQG
K1149 GMPAKRRKTMQGEGP
T1150 MPAKRRKTMQGEGPQ
T1177 AAGARPLTSPESLSR
S1178 AGARPLTSPESLSRD
Y1213 RLQEDPNYSPQRFPN
S1214 LQEDPNYSPQRFPNA
  BAT3 iso5  
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
- gap
T15 PSLVSWLTTMMGLRL
P49 RVGDPPQPLPEEPME
A63 EVQGAERAsPEPQEW
S64-p VQGAERAsPEPQEWV
- gap
- gap
- gap
- gap
K85 IQSQRKVKPQPPLSD
K101 YLSGMPAKRRKLRSD
K104 GMPAKRRKLRSDIQK
- gap
- gap
- gap
Y119 RLQEDPNYSPQRFPN
S120 LQEDPNYSPQRFPNA
  mouse

 
- gap
S6 __MEPSDSASTAMEE
K22 DSLEVLVKTLDSQTR
S26 VLVKTLDSQTRTFIV
K40-u VGAQMNVkEFKEHIA
K56-u SVSIPSEkQRLIYQG
K56 SVSIPSEKQRLIYQG
K70 GRVLQDDKkLQEYNV
K71-u RVLQDDKkLQEYNVG
K80-u QEYNVGGkVIHLVER
S106 SSGTGSASATHGGAP
P113 SATHGGAPLPGTRGP
T117 GGAPLPGTRGPGASV
S181 RDIQTLLSRMECRGG
S213 SETVALNSQTSEPVE
A351 LRCNLACAPPRHLHV
P719 GLGPESLPPEFFTSV
Y840 LITGLEEYVRESFSL
T937 PSLVSWLTTMMGLRL
T971-p RVGDPPQtLPEEPME
T985-p EVQGAERtsPEPQRE
S986-p VQGAERtsPEPQREN
S995-p EPQRENAsPAPGttA
T1000-p NAsPAPGttAEEAMS
T1001-p AsPAPGttAEEAMSR
D1023 GGSRDEQDGASADAE
K1055-u IQSQRKVkPQPPLSD
K1071 YLSGMPAKRRktMQG
K1074-u GMPAKRRktMQGEGP
T1075-p MPAKRRktMQGEGPQ
T1102 AAGARPLTsPESLSR
S1103-p AGARPLTsPESLSRD
Y1138-p RLQEDPNysPQRFPN
S1139-p LQEDPNysPQRFPNA
  rat

 
- gap
S6 __MEPSDSTSTAMEE
K22 DSLEVLVKTLDSQTR
S26 VLVKTLDSQTRTFIV
K40 VGAQMNVKEFKEHIA
K56 SVSIPSEKQRLIYQG
K56 SVSIPSEKQRLIYQG
K70 GRVLQDDKKLQDYNV
K71 RVLQDDKKLQDYNVG
K80 QDYNVGGKVIHLVER
S106 SSGTGSASATHGGGP
P113 SATHGGGPLPGTRGP
T117 GGGPLPGTRGPGASG
S181 RDIQTLLSRMECRGG
S212 SETVALNSQTSEPVE
A345 LRCNLACAPPRHLHV
P711 GLGPESLPPEFFTSV
Y832 LITGLEEYVRESFSL
T929 PSLVSWLTTMMGLRL
A963 RIGDPPQALPEEPME
T977-p EVQGAERtSPEPQRE
S978 VQGAERtSPEPQRED
S987 EPQREDASPAPGTTA
T992 DASPAPGTTAEEAMS
T993 ASPAPGTTAEEAMSR
D1015 GGSRDEQDGASADAE
K1047 IQSQRKVKPQPPLSD
K1063 YLSGMPAKRRKTMQG
K1066 GMPAKRRKTMQGEGP
T1067 MPAKRRKTMQGEGPQ
T1094 AAGARPLTSPESLSR
S1095 AGARPLTSPESLSRD
Y1130 RLQEDPNYSPQRFPN
S1131 LQEDPNYSPQRFPNA
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.